Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: a randomized trial of regimen switch to atazanavir
JA Beckman, BR Wood, KL Ard, CN Price… - PLoS …, 2017 - journals.plos.org
Bilirubin acts as a potent endogenous antioxidant, with higher concentrations associated
with lower rates of CVD; the antiretroviral drug atazanavir (ATV) increases bilirubin levels …
with lower rates of CVD; the antiretroviral drug atazanavir (ATV) increases bilirubin levels …
Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population
S Bagchi, SAB Burrowes, LE Fantry… - SAGE Open …, 2017 - journals.sagepub.com
Objective: To determine factors associated with increased risk of developing cardiovascular
disease in a high-risk patient population. Design: Cross-sectional analysis of a retrospective …
disease in a high-risk patient population. Design: Cross-sectional analysis of a retrospective …